The primary purpose of the Strategy & Corporate Development and Finance Coordinator is to provide comprehensive coordination, analyst and logistical support to the Strategy & Corporate Development. This includes managing high profile external meeting coordination with investment banks, VCs, biotech and Pharma execs, internal meeting planning involving senior management and highly cross functional support, coordinating travel and event logistics, handling invoicing and expenses, and maintaining accurate records. Additionally, the role includes providing administration and coordination support the Strategy & Corporate Development and Finance team and other designated business leaders in managing global activities. The role is essential in ensuring the Strategy & Corporate Development and Finance team can effectively engage with high profile external and internal stakeholders, enabling effective functioning of the team to overall success of these departments.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.